Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

4 results
Display

Prostaglandin A2 Induces Caspase-independent Apoptosis in Hepatocellular Carcinoma Cells

Kim HS, Shim JC, Choi JY, Rhim H, Kim IK

  • KMID: 760582
  • Korean J Hepatol.
  • 2005 Mar;11(1):72-79.
BACKGROUND/AIMS: Prostaglandin (PG) A2 has been reported to inhibit the growth of hepatocellular carcinoma cells via activation of apoptosis, although the molecular mechanisms involved have not been clarified, yet....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
D4-GDI is cleaved by caspase-3 during daunorubicin-induced apoptosis in HL-60 cells

Kwon KB, Park EK, Ryu DG, Park BH

  • KMID: 1093595
  • Exp Mol Med.
  • 2002 Mar;34(1):32-37.
Daunorubicin, an anti-cancer drug, is known to induce apoptosis in HL-60 cells in a dose-dependent manner through the activation of caspase-3 (CPP32). Caspase-3 selective inhibitor, Ac-DEVD-CHO, prevented both the activation...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pseudolaric acid B induces apoptosis via activation of c-Jun N-terminal kinase and caspase-3 in HeLa cells

Gong X, Wang M, Wu Z, Tashiro SI, Onodera S, Ikejima T

  • KMID: 1103322
  • Exp Mol Med.
  • 2004 Dec;36(6):551-556.
Pseudolaric acid B was isolated from Pseudolarix kaempferi Gordon (Pinaceae) and was evaluated for the anti-cancer effect in HeLa cells. We observed that pseudolaric acid B inhibited cell proliferation and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Norcantharidin Induces Human Melanoma A375-S2 Cell Apoptosis through Mitochondrial and Caspase Pathways

An WW, Wang MW, Tashiro SI, Onodera S, Ikejima T

Norcantharidin (NCTD) is the demethylated form of cantharidin, which is the active substance of mylabris. To examine the pathway of NCTD-induced A375-S2 cell death, 3-(4, 5-dimethylthiazol-2-yl)-2, 5-dipheyltetrazolium bromide (MTT) assay,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr